SHALLAK, MARIAM
 Distribuzione geografica
Continente #
NA - Nord America 236
EU - Europa 221
AS - Asia 11
Totale 468
Nazione #
US - Stati Uniti d'America 235
IT - Italia 141
SE - Svezia 25
IE - Irlanda 19
DE - Germania 17
UA - Ucraina 8
GB - Regno Unito 6
VN - Vietnam 6
FI - Finlandia 2
FR - Francia 2
IN - India 2
CA - Canada 1
CN - Cina 1
HK - Hong Kong 1
JP - Giappone 1
MD - Moldavia 1
Totale 468
Città #
Milan 49
Como 30
Ashburn 28
Chandler 26
Fairfield 20
Nyköping 20
Dublin 19
New York 18
Seattle 11
Woodbridge 11
Princeton 10
Wilmington 9
Ann Arbor 8
Jacksonville 7
Magnago 7
Houston 6
Berlin 5
Dong Ket 5
Ogden 5
Cambridge 4
Naples 4
Rome 4
Washington 4
West Jordan 4
Vanzago 3
Aprilia 2
Bergamo 2
Helsinki 2
London 2
Los Angeles 2
Norwalk 2
Pune 2
San Diego 2
Wilnsdorf 2
Alzate Brianza 1
Beijing 1
Chicago 1
Edinburgh 1
Frankfurt am Main 1
High Point 1
Hounslow 1
Kilburn 1
Legnano 1
Messina 1
Parrano 1
Prescot 1
Redmond 1
Redwood City 1
Siena 1
Toronto 1
Turin 1
Varese 1
Vicenza 1
Totale 354
Nome #
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1 99
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 76
Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T cell leukemia 69
Unveiling the hidden treasury: Ciita-driven mhc class ii expression in tumor cells to dig up the relevant repertoire of tumor antigens for optimal stimulation of tumor specific cd4+ t helper cells 53
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells 46
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma 37
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 36
Htlv-1 infection and pathogenesis: New insights from cellular and animal models 31
A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line 14
Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA 14
The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing 14
HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity 6
The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy 1
Totale 496
Categoria #
all - tutte 2.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 4 6 10 5 3 1 2
2020/202160 1 2 3 2 1 3 4 4 19 8 5 8
2021/202270 5 1 2 6 1 5 1 10 9 9 15 6
2022/2023140 9 3 10 5 18 21 1 19 21 10 19 4
2023/2024195 21 11 21 48 38 37 1 6 6 6 0 0
Totale 496